Empiric PPI therapy or endoscopy for the initial management of patients with GERD in the absence of alarm features? Commentary

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 5, Issue 10, 2008, Pages 548-549

  Vela, Marcelo F ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE; PROTON PUMP INHIBITOR;

CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG RESPONSE; DRUG TREATMENT FAILURE; ENDOSCOPIC THERAPY; GASTROESOPHAGEAL REFLUX; HUMAN; INTERMETHOD COMPARISON; PATIENT MONITORING; PRIORITY JOURNAL; PROVOCATION TEST; QUALITY OF LIFE; REFLUX ESOPHAGITIS; SENSITIVITY AND SPECIFICITY; SHORT SURVEY;

EID: 53749083283     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep1228     Document Type: Short Survey

References (5)

1. Giannini EG et al. (2008) Management strategy for patients with gastroesophageal reflux disease: A comparison between empirical treatment with esomeprazole and endoscopy-oriented treatment. Am J Gastroenterol 103: 267-275
2. DeVault KR and Castell DO (2005) Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 100: 190-200
3. Fass R et al. (2005) Systematic Review: Proton-pump inhibitor failure in gastro-oesophageal reflux disease-where next? Aliment Pharmacol Ther 22: 79-94
4. Dean BB et al. (2004) Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol 2: 656-664
5. Numans ME et al. (2004) Short-term treatment with proton-pump inhibitors as a test for gastroesopahgeal reflux disease. Ann Intern Med 140: 518-527